Guided Therapeutics (GTHP) Assets Average (2012 - 2025)

Guided Therapeutics has disclosed Assets Average across 14 years of filings, most recently posting $1.1 million for Q4 2025.

• Assets Average for Q4 2025 came in at $1.1 million, down 15.23% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.1 million (down 15.23% YoY), and the FY2025 annual result was $1.4 million, down 11.32% from the prior year.
• Assets Average came in at $1.1 million for Q4 2025 at Guided Therapeutics, up from $921500.0 in the prior quarter.
• In the past five years, Assets Average ranged from a high of $3.6 million in Q4 2022 to a low of $921500.0 in Q3 2025.
• The 5-year median for Assets Average is $1.9 million (2021), against an average of $1.9 million.
• Across the five-year window, Assets Average surged 239.13% in 2021 and plunged 51.0% in 2023, its largest moves.
• Guided Therapeutics' Assets Average stood at $1.9 million in 2021, then soared by 91.25% to $3.6 million in 2022, then slumped by 51.0% to $1.8 million in 2023, then retreated by 25.92% to $1.3 million in 2024, then dropped by 15.23% to $1.1 million in 2025.
• The last three Assets Average figures came in at $1.1 million (Q4 2025), $921500.0 (Q3 2025), and $953500.0 (Q2 2025), per Business Quant data.